Drug Profile
Quinidine extended release - Beijing CoSci Med Tech
Latest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator Beijing CoSci Med-Tech
- Class Antiarrhythmics; Antimalarials; Cinchona alkaloids; Class Ia antiarrhythmics; Quinolines; Quinuclidines; Small molecules
- Mechanism of Action Cytochrome P 450 enzyme system inhibitors; KATP channel inhibitors; Muscarinic receptor antagonists; Voltage-gated sodium channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Atrial fibrillation; Atrial flutter; Ventricular arrhythmias
Most Recent Events
- 03 Aug 2016 Chemical structure information added
- 22 Jul 2016 Investigation in Atrial fibrillation in China (PO)
- 22 Jul 2016 Investigation in Atrial flutter in China (PO)